Date:11/10/2011

illion in G&A), respectively.  Condensed Consolidated Balance Sheets
(in thousands)September 30,December 31,20112010ASSETS(Unaudited)Current Assets:Cash and cash equivalents$
5,411$
,211Prepaid expenses and other current assets327285Total current assets15,73810,496Property and equipment, net 2,5853,467Other assets400574Total Assets$
8,723$
4,537LIABILITIES AND STOCKHOLDERS' EQUITYCurrent Liabilities:Accounts payable$
,386$
,685Accrued expenses3,0033,286Common stock warrant liability8,5992,469Equipment loan and capitalized leases, current portion74136Total Current Liabilities13,0627,576Long-Term Liabilities:Equipment loan  and capitalized leases, non-current portion & other liabilities933935Total Liabilities13,9958,511Stockholders' Equity4,7286,026Total Liabilities and Stockholders' Equity$
8,723$
4,537
'/>"/>

SOURCE Discovery Laboratories, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9
Related biology technology :

1. Affitech and Omeros Enter Into Antibody Discovery and Development Agreement
2. Concentric Named Professional Agency of Record for Discovery Labs SURFAXIN(R)
3. ChanTest to Highlight the Worlds Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Ion Channel Targets, Booth 5
4. Biotechnology & Drug Discovery Markets Push Up Demand for Lab Automation Products, According to a New Report by Global Industry Analysts
5. Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atrophy (SMA)
6. ChanTest to Highlight the Worlds Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Assays & Cellular Targets Conference, Booth 11
7. Affitech Announces Second Milestone in Roche Antibody Discovery Collaboration
8. The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
9. Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
10. deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer
11. Global Drug Discovery Technologies Market to Exceed $57 Billion by 2012, According to a New Report by Global Industry Analysts